Jim Healy
Managing Partner · Sofinnova Investments
General PartnerMenlo Park, CA
Jim Healy, MD, PhD, is Managing Partner of Sofinnova Investments in Menlo Park, where he has invested in 32 biotech and healthcare companies over a roughly twenty-year career with the firm. His BIO convention bio says 22 of his investments have gone public and 11 have been acquired, and that he has funded companies where 13 products were approved by the FDA or EMA.
Board seats
33 current
· PUBLIC SOURCES
Credited hits
3
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Jim Healy, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- Karuna Therapeuticsacquired
Healy was a director involved in the Karuna exit; acquired by Bristol Myers Squibb, per Wikipedia's Sofinnova summary.
Source: en.wikipedia.org
- CinCor Pharmaacquired
Healy was a director involved in the CinCor exit; acquired by AstraZeneca, per Wikipedia's Sofinnova summary.
Source: en.wikipedia.org
- Nateraipo
WSJ Pro coverage names Natera, which went public in 2015, among Healy's greatest hits at Sofinnova.
Source: wsj.com
Board seats
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
Contact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- www.sofinnova.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Jim Healy. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Jim Healy.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Jim Healy — provenance: GlassVC extended catalog, November 2026
↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats · Reputation
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
